Researchers at MIT are leveraging artificial intelligence to enhance the delivery mechanisms of RNA vaccines and therapies, potentially revolutionizing disease treatment and prevention.
Leveraging advanced generative AI techniques, researchers have made promising strides in the design of novel antibiotics capable of combating drug-resistant bacteria like MRSA.
As large language models continue to pervade our daily interactions, the need for reliable methods to evaluate their accuracy becomes crucial. A new approach from MIT aims to enhance the understanding of how well these AI systems classify text, ensuring they are as dependable as they are prevalent.
In a world where artificial intelligence increasingly drives innovation, Cloudian—a data storage company co-founded by an MIT alumnus—enables businesses to effectively manage the vast amounts of data AI models demand. Cloudian's solutions are designed to support the extensive data needs of machine learning systems while ensuring scalability and efficiency.
As ChatGPT continues to evolve, staying updated on its functionalities and releases is crucial. Developed by OpenAI, ChatGPT is a cutting-edge AI chatbot that can engage in text-based conversations, offering seamless interactions across various applications. This article highlights its latest updates and innovations by exploring its development timeline.
Sweden's BoardClic has secured €1.65 million to enhance its AI-driven solutions, aiming to revolutionize boardroom processes and governance across Europe.
Europe is rapidly carving out a pivotal role in the global AI landscape, with a flourishing array of companies poised for international prominence, according to Ziv Reichert of LocalGlobe.
Mukesh Ambani, chairman of Reliance Industries, is collaborating with tech giants Google and Meta to develop a robust AI infrastructure in India. This initiative includes plans for a partnership with OpenAI, as Reliance aims to drive the country's AI aspirations forward.
MIT scientists unveil VaxSeer, a cutting-edge AI tool that enhances the selection of flu vaccine strains by predicting virus evolution and antigenicity. This innovation aims to significantly improve the efficacy of vaccines and reduce dependence on traditional guessing methods.
Anthropic, a leading AI research and deployment company, is implementing a new policy requiring users to explicitly opt out if they do not wish for their conversation data to be used in AI training. This move, set to take effect by September 28, raises crucial questions about privacy and consent in the rapidly evolving AI sector.
Stay informed with curated insights delivered weekly to your inbox.